Beacon Targeted Therapies
Beacon Targeted Therapies, a competitive and research intelligence database solution designed in partnership with pharmaceutical professionals across the world working in targeted therapies to provide accurate, in-depth and real-time information in the rapidly evolving landscape of drug development.
Find out more on how we can help you by visiting www.beacon-intelligence.com.
Absorption Systems offers de novo development, optimization, qualification, validation, and GMP-compliant final product and product release testing services for both allogeneic and autologous therapies. We develop both in vitro and in vivo models to better predict human outcomes and correlations between animal studies and in vitro cell-based assays. With over 25 years of expertise, Absorption Systems develops proprietary assays, leveraging our skills in cell and molecular biology, assay development and validation, bioanalytical and immunochemical quantitation, statistical analysis and regulatory affairs within a single-source collaboration. Learn more at www.absorption.com.